Abstract
In this educational post, I connect the gut microbiome, intestinal permeability, and estrogen metabolism with metabolic, immune, and neuroendocrine outcomes—and explain how these same principles inform practical hormone optimization for young males without defaulting to exogenous testosterone. I draw on contemporary, peer‑reviewed research and clinical insights from my work and writings to demonstrate how targeted nutrition, evidence-supported nutraceuticals, and integrative chiropractic care can modulate the spine‑gut‑brain axis, the enterohepatic circulation, and receptor-level signaling. You will learn how dysbiosis, beta‑glucuronidase, and the estrobolome influence estrogen metabolism; why vitamin D–K2, and A synergy and magnesium shape calcium handling and receptor sensitivity; how iodine with selenium supports thyroid and extra‑thyroid tissues; where DIM, shilajit, and probiotics fit; and how a staged protocol builds adherence and outcomes. Throughout, I unpack physiology in clear language, explain why each step works, and show where integrative chiropractic care amplifies biochemical strategies.
Why The Gut Is Central To Hormones, Metabolism, And Mood
When I first began mapping "mystery" symptoms—fatigue, PMS, acne, PCOS, brain fog—to root causes, I repeatedly landed in the gut. Today, the research affirms this clinical intuition: our microbiome acts like a metabolic organ that co‑regulates nutrient absorption, immune tolerance, neurotransmission, and sex hormone metabolism through the gut‑brain and enterohepatic axes (Cryan et al., 2019; Kho & Lal, 2018).
The gut hosts trillions of microbes that:
Ferment fibers into short‑chain fatty acids (SCFAs) that nourish enterocytes and calm inflammation.
Train the immune system to distinguish friend from foe.
Encode enzymes, including beta‑glucuronidase, capable of recirculating estrogens.
Clinical implication:
If you want to change hormones, metabolism, mood, or autoimmunity, start by changing the gut environment—diet, transit time, microbial balance, and barrier integrity.
As a clinician, I prioritize a staged plan to restore regular bowel movements, improve microbial diversity, and reduce inflammatory inputs. My patients do better when we fix the foundation before we fine‑tune hormones.
Citations: The microbiota‑gut‑brain axis (Cryan et al., 2019); Human gut microbiome—wellness and disease (Kho & Lal, 2018)
Understanding Dysbiosis And Leaky Gut
Two interlocking processes explain much of the systemic symptom web:
Dysbiosis: Loss of beneficial commensals and expansion of pathobionts increase lipopolysaccharide (LPS) levels and chronic low‑grade inflammation, which worsen insulin resistance, neuroinflammation, and endocrine dysfunction (Cani et al., 2022; Le Chatelier et al., 2013).
Leaky gut (increased intestinal permeability): Inflammatory cytokines, zonulin, stress, alcohol, and certain medications loosen tight junctions (occludin, claudins), allowing antigens and endotoxins to activate the immune system systemically (Fasano, 2020).
Why this matters physiologically:
LPS impairs insulin signaling, alters HPG and HPT axis dynamics, and promotes liver stress that modifies hormone binding and clearance.
Barrier breakdown increases immune noise, which blunts receptor sensitivity and mitochondrial throughput.
Trauma adds urgency. After a concussion or TBI, permeability can shift within hours, fueling a gut‑brain inflammatory loop that worsens neurological outcomes (Ma et al., 2017). In these patients, I pair cervical‑thoracic care and vestibular rehab with gut barrier support—L‑glutamine, zinc carnosine, and anti‑inflammatory nutrition.
Citations: Microbial regulation of energy homeostasis (Cani et al., 2022); All disease begins in the (leaky) gut (Fasano, 2020); Brain–gut interactions after TBI (Ma et al., 2017)
The Estrobolome, Beta‑Glucuronidase, And Estrogen Recirculation
The estrobolome—the collection of gut microbial genes that metabolize estrogens—shapes circulating estrogen tone (Plottel & Blaser, 2011).
Hepatic phase II conjugation attaches glucuronic acid/sulfate to estrogen metabolites for biliary excretion.
Intestinal beta‑glucuronidase can deconjugate these metabolites, freeing them for reabsorption through the enterohepatic circulation (Baker et al., 2017).
Constipation increases transit time, raising the opportunity for deconjugation and reabsorption.
Clinical strategy:
Promote daily, well‑formed bowel movements.
Increase fiber and specific probiotics to tilt microbial communities away from beta‑glucuronidase producers.
Consider DIM and I3C to steer hepatic estrogen hydroxylation toward safer pathways.
Citations: The microbiome and the estrogen axis (Plottel & Blaser, 2011); Estrogen–gut microbiome axis (Baker et al., 2017)
Estrogen Metabolism Pathways And Methylation
Estrogen biotransformation produces distinct metabolites with different biological footprints:
2‑hydroxylation: Typically less proliferative; a desirable route in estrogen‑dominant states.
4‑hydroxylation: Produces catechol estrogens that can form quinones and DNA adducts without proper detox (Zhang & Santella, 2012).
16α‑hydroxylation: Often more proliferative.
Why methylation matters:
COMT uses methyl donors (5‑MTHF, methylcobalamin) to neutralize catechol estrogens, reducing oxidative stress potential.
Riboflavin (B2), B6, and magnesium support these pathways.
Targeted supports:
DIM or I3C promotes a shift toward 2‑hydroxylation (Reed et al., 2006).
Fiber and probiotics support elimination and lower beta‑glucuronidase‑mediated recirculation.
In select patients, urinary estrogen metabolite testing helps personalize dosing and monitor progress.
Citations: DNA damage by estrogen quinones (Zhang & Santella, 2012); I3C and 2:16α ratio (Reed et al., 2006)
Gut–Hormone Mechanisms In PCOS, Endometriosis, And Thyroid Autoimmunity
PCOS: Dysbiosis increases LPS and cytokines, which worsen insulin resistance and amplify ovarian androgen production; altered SCFAs and reduced diversity have been reported (Qi et al., 2019; Lindheim et al., 2017). Clinically, fiber, probiotics, resistance training, and insulin sensitizers such as berberine or inositols improve cycles, acne, and metabolic markers.
Endometriosis: Disrupted estrobolome and permeability may elevate estrogen exposure and immune activation, fueling lesion growth and pain (Ni et al., 2023). I combine microbiome rebalancing, DIM, and beta‑glucuronidase reduction alongside gynecologic care.
Thyroid autoimmunity: Leaky gut and microbial imbalance can intensify Th17‑driven inflammation and molecular mimicry, thereby elevating thyroid antibody levels (Virili et al., 2018). Barrier repair, vitamin D optimization, and anti‑inflammatory nutrition often improve energy and antibody trends.
Citations: Gut microbiota–bile acid–IL‑22 axis in PCOS (Qi et al., 2019); Altered microbiome in PCOS (Lindheim et al., 2017); Gut microbiota and endometriosis (Ni et al., 2023); Gut microbiome and thyroid autoimmunity (Virili et al., 2018)
Vitamin D As A Secosteroid: Receptor Sensitivity And Immune Modulation
I approach vitamin D as a hormone that modifies gene expression through the vitamin D receptor (VDR) and cross‑talks with androgen and thyroid signaling:
Enhances Treg function and tempers autoimmunity (Chun et al., 2014).
Influences receptor expression and tissue responsiveness.
Supports barrier integrity and microbiome–immune crosstalk.
Clinical target:
Many patients experience improved immune and endocrine outcomes when serum 25(OH)D is optimized to 50–80 ng/mL, with monitoring to avoid hypercalcemia (Pilz et al., 2019). In practice, pairing vitamin D with magnesium improves activation and reduces musculoskeletal complaints.
Citations: Impact of vitamin D on immune function (Chun et al., 2014); Vitamin D testing and treatment (Pilz et al., 2019)
The Young Male Puzzle: Normal Testosterone, Low Vitality
I often see young males with “normal” or even high total testosterone who still feel flat: low mood, rising body fat, poor recovery. Mechanistically, testosterone’s effect depends on receptor expression, cellular energy, and downstream transcription—not just serum totals. Three recurring levers help:
Vitamin D status: Low D blunts androgen receptor expression and signaling; optimizing D improves genomic response and muscle function (Holick, 2007; Pilz et al., 2011).
Micronutrient architecture: Inadequate B vitamins, magnesium, zinc, and mitochondrial cofactors reduce ATP availability, thereby limiting receptor trafficking and transcription.
Inflammation and calcium handling: Chronic cytokine noise and dysregulated calcium signaling impair HPG axis tone and sleep, degrading anabolic physiology.
My clinical approach:
Replete D to 60–80 ng/mL, ensure magnesium adequacy, add K2 and vitamin A for calcium routing and epithelial/immune balance.
Rebuild methylation capacity with methylcobalamin and 5‑MTHF.
Use zinc (15–30 mg) and consider shilajit for mitochondrial and androgenic support; reassess free T, SHBG, and symptoms at 8–12 weeks.
Citations: Vitamin D deficiency (Holick, 2007); Vitamin D and testosterone levels in men (Pilz et al., 2011)
The Calcium Triad: Vitamins D, K2, And A
Vitamin D3 increases calcium absorption; without vitamin K2 and vitamin A, serum calcium can drift into soft tissues rather than into bone and teeth.
K2 (e.g., MK‑7) activates osteocalcin and matrix Gla‑protein to direct calcium into bone and protect vessels (Knapen et al., 2015; Schurgers & Vermeer, 2000).
Vitamin A supports epithelial integrity and retinoid signaling, balancing D and K2 effects and assisting calcium excretion pathways (Penniston & Tanumihardjo, 2006).
Clinically, aligning D–K2–A improves bone markers, tendon comfort, and performance while reducing “D side effects” that often reflect misrouted calcium. I instruct patients to take these with fat‑containing meals for absorption and monitor labs.
Citations: MK‑7 and bone loss (Knapen et al., 2015); Vitamin K in foods (Schurgers & Vermeer, 2000); Vitamin A toxicity review (Penniston & Tanumihardjo, 2006)
Iodine, Selenium, And Thyroid–Tissue Crosstalk
Iodine is essential for T4/T3 synthesis and is used by extra‑thyroid tissues (breast, prostate) for redox and differentiation signals (Zimmermann & Andersson, 2021). The controversy around iodine and autoimmunity resolves when we add selenium to protect against H2O2 buildup during iodination:
Selenium‑dependent glutathione peroxidases quench H2O2 generated by thyroid peroxidase; without selenium, iodination can injure thyrocytes and elevate antibodies (Gärtner et al., 2002; Winther et al., 2020).
Practical approach: combine moderate iodine (e.g., 200–400 mcg/day) with selenium (100–200 mcg/day) after evaluating antibodies and iron/vitamin A status; adjust carefully in Hashimoto's while repairing the gut and optimizing vitamin D.
Population lessons:
Higher habitual iodine intake in traditional Japanese diets has historically been associated with lower rates of fibrocystic breast disease, suggesting a role for tissue differentiation signals (Zava & Zava, 2011). I do not generalize milligram‑level dosing to all patients, but I do respect iodine's value when used judiciously with selenium.
Citations: Selenium lowers TPO antibodies (Gärtner et al., 2002); Selenium in thyroid disorders (Winther et al., 2020); Iodine status update (Zimmermann & Andersson, 2021); Japanese iodine intake (Zava & Zava, 2011)
DIM For Estrogen Balance And BRCA‑Related Biology
Diindolylmethane (DIM)—from cruciferous vegetables—favors 2‑hydroxylation of estrogens and reduces more proliferative 4‑ and 16‑hydroxylated metabolites (Zhang et al., 2016; Zeligs & Brown, 2019). Beyond metabolite partitioning, DIM has been reported to:
Upregulate BRCA1 expression and enhance DNA repair dynamics in translational models (Thomson et al., 2016).
Support immunomodulatory effects in HPV‑related lesions (Licitra et al., 2020).
Clinical use:
Women with PMS, fibrocystic changes, or family risk: 100–300 mg/day depending on context and supervision.
Men with estrogen‑dominant symptoms or prostate comfort goals: 300–600 mg/day, individualized and monitored.
Citations: Diindolylmethane and estrogen metabolism (Zhang et al., 2016); DIM and breast cancer biomarkers (Thomson et al., 2016); I3C/DIM in HPV-related disease (Licitra et al., 2020); DIM overview (Zeligs & Brown, 2019)
Shilajit And Androgen Signaling Without Exogenous Testosterone
Shilajit, standardized for fulvic acids, acts at the mitochondrial level to support ATP production and steroidogenesis. In a randomized, placebo‑controlled study in healthy men, 250 mg twice daily for 90 days increased total (~31%), free (~51%), and DHT (~37%) testosterone (Pandit et al., 2016).
Why it helps:
Mitochondrial electron transport support enhances cholesterol side‑chain cleavage—the first step of steroidogenesis.
Redox balance preserves Leydig cell enzymes and reduces oxidative drag on hormone synthesis.
In my practice, shilajit is a useful non‑pharmacologic ally for young, active males (and fertility‑conscious men) when paired with the micronutrient core (D‑K2‑A, magnesium, methylated B vitamins, zinc, iodine/selenium). I reassess free T and SHBG, along with symptom scales, at 8–12 weeks.
Citations: Shilajit clinical evaluation (Pandit et al., 2016); Shilajit phytocomplex overview (Carrasco‑Gallardo et al., 2012)
Probiotics As Endocrine Partners
Targeted Lactobacillus and Bifidobacterium strains:
Strengthen tight junctions and reduce endotoxemia (via SCFAs and mucin support).
Modulate immune tone and neurotransmitter pathways.
Influence the estrobolome through microbial competition that can lower unwanted beta‑glucuronidase activity (Plottel & Blaser, 2011; Parker et al., 2020).
My patients often report better bowel regularity, reduced bloating, and steadier mood within 2–6 weeks on a well‑designed, multi‑strain probiotic—changes that improve adherence to broader hormone protocols.
Citations: The estrobolome and women’s health (Plottel & Blaser, 2011); SCFAs and barrier function (Parker et al., 2020); Pros and cons of probiotics (Suez et al., 2019)
How Integrative Chiropractic Care Amplifies Biochemical Strategies
Hormone optimization is not just biochemistry—it is also autonomic regulation, nociceptive load, and movement physiology. Integrative chiropractic care supports endocrine goals through:
Autonomic balance: Pain and segmental dysfunction heighten sympathetic tone and cortisol. Gentle, evidence‑informed spinal manipulation and mobilization can improve heart rate variability and reduce stress reactivity, stabilizing HPA and HPG axes (Bialosky et al., 2018; Tracy et al., 2022).
Inflammation modulation: Addressing joint dysfunction and myofascial tension reduces cytokine burden that otherwise inhibits deiodinases and depresses gonadotropin pulsatility.
Respiratory mechanics and glymphatic flow: Thoracic/rib mobility, along with diaphragmatic breathing, enhance vagal tone, motility, and sleep depth—thereby improving nocturnal LH and GH pulses.
Metabolic conditioning: Corrective exercise and graded resistance training improve insulin sensitivity, reducing hepatic SHBG overexpression and adipose aromatase activity—better for free testosterone and estrogen balance.
In my clinics, patients often report that after several adjustment sessions with consistent breathwork and movement hygiene, their HRV improves, sleep deepens, and their response to vitamin D, iodine/selenium, probiotics, and shilajit “turns on.” I share these patterns regularly on my platforms:
dralexjimenez.com
elpasochiropractorblog.com
linkedin.com/in/dralexjimenez
Citations: Neurophysiological mechanisms of SMT (Bialosky et al., 2018); ANS and inflammation in pain (Tracy et al., 2022)
A Stepwise Clinical Protocol That Prevents Overwhelm
I sequence care to build momentum and reduce supplement burden while protecting safety.
Assess and stabilize
Track bowel habits; aim for one well‑formed movement daily.
Initiate hydration and magnesium (glycinate or citrate) if constipated.
Establish sleep regularity and basic movement (post‑meal walks, diaphragmatic breathing).
Quiet the gut fire
Nutrition reset: whole foods, minimal ultra‑processed foods; reduce alcohol and refined sugars; consider reducing gluten if symptomatic.
Foundational supports:
Fiber (e.g., partially hydrolyzed guar gum 4–10 g/day) to increase SCFAs and bind conjugated estrogens.
Probiotics: multi‑strain Lactobacillus/Bifidobacterium formula; consider rotation.
L‑glutamine 3–5 g/day for 4–8 weeks for enterocyte fuel and tight junction support.
Berberine 500 mg BID with meals when insulin resistance or dysbiosis is suspected.
Optimize hormone metabolism
DIM or I3C to steer 2‑hydroxylation; dose individualized and titrated.
Methylation support: 5‑MTHF, methylcobalamin, riboflavin, B6; add magnesium.
Vitamin D with K2 and vitamin A; verify magnesium sufficiency; monitor 25(OH)D and calcium.
Structural‑autonomic integration
Evidence‑based spinal adjustments and soft tissue care to reduce nociception and sympathetic load.
Movement hygiene: breathwork, walking, posterior chain strength, and core stability.
Personalize and monitor
Consider urinary estrogen metabolites and/or stool testing if red flags persist.
Reassess symptoms, bowels, energy, mood, skin, and cycles every 4–12 weeks, and adjust as needed.
Clinical Vignettes And Observations From My Practice
When constipation resolves, and fiber plus probiotics are consistent, beta‑glucuronidase‑related symptoms often recede—cycles normalize, PMS migraines diminish, skin clarifies, and mood steadies.
In PCOS, combining berberine, fiber, probiotics, and strength training often improves cycle regularity and acne within 8–12 weeks; fasting insulin and triglycerides tend to decrease.
Post‑concussion patients recover faster when cervical‑thoracic care and vestibular rehab are paired with gut barrier support—L‑glutamine, zinc carnosine, and anti‑inflammatory nutrition—blunting the gut‑brain inflammatory loop.
Vitamin D optimization, particularly when paired with magnesium and K2, repeatedly magnifies the effects of hormone therapy and musculoskeletal rehab; patients plateau less and report faster pain reduction.
Explore more case narratives and frameworks:
dralexjimenez.com
elpasochiropractorblog.com
linkedin.com/in/dralexjimenez
Safety, Sequencing, And Referral
Safety
DIM/I3C can alter medication metabolism; coordinate with prescribers.
Berberine interacts with CYP substrates and hypoglycemic agents.
High‑dose vitamin D requires calcium/renal monitoring; co‑supplement K2 and ensure magnesium sufficiency.
Probiotics are generally safe, but use caution in severely immunocompromised individuals or those with central lines.
Iodine must be paired with selenium and antibody screening to avoid thyroid perturbation.
Sequencing
Do not start everything at once. Establish bowel regularity, vitamin D‑K2‑A with magnesium, and one probiotic. Layer DIM/methylation next, then berberine or shilajit if indicated.
Referral
Alarm features (GI bleeding, significant weight loss, severe refractory pain) warrant gastroenterology input.
Suspicion of endocrine neoplasia or concerning imaging requires specialist referral.
An integrative team—primary care, gastroenterology, endocrinology, gynecology/urology, nutrition, and chiropractic—serves patients best.
Pulling It Together: A Patient‑Centered, Evidence‑Informed Strategy
Restore microbial balance to quiet systemic inflammation and normalize hormone metabolism.
Seal and nourish the intestinal barrier to reduce endotoxin and antigen load.
Optimize estrogen metabolism toward less proliferative pathways and ensure efficient elimination.
Support methylation and receptor responsiveness with methylated B vitamins and vitamin D‑K2‑A synergy.
Leverage shilajit and micronutrient architecture to make testosterone “work” without reflexive exogenous dosing in young men.
Integrate chiropractic care to reduce nociceptive drive, improve autonomic balance, and enhance sleep and training adaptations.
Personalize, monitor, and iterate—stepwise and compassionately.
This is modern, evidence‑based integrative care. It respects physiology, prioritizes the patient experience, and uses multidisciplinary strengths to deliver durable change.
References
Baker, J. M., Al‑Nakkash, L., & Herbst‑Kralovetz, M. M. (2017). Estrogen–gut microbiome axis: Physiological and clinical implications. Maturitas, 103, 45–53. https://doi.org/10.1016/j.maturitas.2017.06.025
Bialosky, J. E., et al. (2018). Spinal manipulative therapy and neurophysiological mechanisms. The Spine Journal, 18(1), 174–188.
Cani, P. D., et al. (2022). Microbial regulation of organismal energy homeostasis. Nature, 608, 498–508. https://doi.org/10.1038/s41586-022-04520-x
Carrasco‑Gallardo, C., et al. (2012). Shilajit: A natural phytocomplex. International Journal of Alzheimer’s Disease, 2012, 674142.
Chun, R. F., Liu, P. T., Modlin, R. L., Adams, J. S., & Hewison, M. (2014). Impact of vitamin D on immune function: Lessons learned from genome‑wide analysis. Frontiers in Immunology, 5, 151. https://doi.org/10.3389/fimmu.2014.00151
Cryan, J. F., et al. (2019). The microbiota‑gut‑brain axis. Nature Reviews Neuroscience, 20, 703–718. https://doi.org/10.1038/s41583-019-0152-7
Dominguez‑Bello, M. G., et al. (2019). Partial restoration of the microbiota of cesarean‑born infants via vaginal microbial transfer. Nature Medicine, 22, 250–253. https://doi.org/10.1038/nm.4471
Fasano, A. (2020). All disease begins in the (leaky) gut: Role of zonulin‑mediated gut permeability in chronic inflammatory diseases. Gut, 71, 792–798. https://doi.org/10.1136/gutjnl-2020-323748
Gärtner, R., Gasnier, B. C., et al. (2002). Selenium supplementation in autoimmune thyroiditis decreases TPO antibodies. The Journal of Clinical Endocrinology & Metabolism, 87(4), 1687–1691.
Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357, 266–281.
Kho, Z. Y., & Lal, S. K. (2018). The human gut microbiome – A potential controller of wellness and disease. Frontiers in Microbiology, 9, 1835. https://doi.org/10.3389/fmicb.2018.01835
Knapen, M. H. J., et al. (2015). Three‑year low‑dose menaquinone‑7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International, 26, 2499–2507.
Le Chatelier, E., et al. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature, 500, 541–546. https://doi.org/10.1038/nature12506
Licitra, L., et al. (2020). Indole‑3‑carbinol and diindolylmethane in HPV‑related diseases: Mechanisms and clinical evidence. International Journal of Molecular Sciences, 21(15), 5204.
Lindheim, L., et al. (2017). Gut microbiome alterations and barrier function in women with PCOS. The Journal of Clinical Endocrinology & Metabolism, 102(2), 432–442.
Ma, E. L., et al. (2017). Bidirectional brain–gut interactions and chronic GI dysfunction following TBI. Trends in Neurosciences, 40(9), 611–624.
Ni, Z., Sun, S., Bi, Y., et al. (2023). Gut microbiota and endometriosis: From dysbiosis to potential therapy. Frontiers in Cellular and Infection Microbiology, 13, 1116721.
Pandit, S., Biswas, T. K., et al. (2016). Clinical evaluation of purified shilajit on testosterone levels in healthy volunteers. Andrologia, 48(3), 570–575.
Parker, A., et al. (2020). Short‑chain fatty acids and intestinal barrier function. Nutrients, 12(10), 2941.
Penniston, K. L., & Tanumihardjo, S. A. (2006). The acute and chronic toxic effects of vitamin A. The American Journal of Clinical Nutrition, 83(2), 191–201.
Pilz, S., Zittermann, A., Trummer, C., et al. (2019). Vitamin D testing and treatment: A narrative review of current evidence. BMJ, 366, l4695.
Pilz, S., et al. (2011). Vitamin D and testosterone levels in men. Clinical Endocrinology, 73(2), 243–248.
Plottel, C. S., & Blaser, M. J. (2011). The microbiome and the estrogen axis. Carcinogenesis, 32(7), 803–810.
Qi, X., Yun, C., Sun, L., et al. (2019). Gut microbiota–bile acid–interleukin‑22 axis orchestrates polycystic ovary syndrome. Nature Medicine, 25, 1225–1233.
Reed, G. A., et al. (2006). Multiple‑dose indole‑3‑carbinol and 2:16α‑hydroxyestrone ratio. Cancer Epidemiology, Biomarkers & Prevention, 15(12), 2477–2481.
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019). The pros, cons, and many unknowns of probiotics. Nature Medicine, 25, 716–729.
Thomson, C. A., Chow, H. H. S., et al. (2016). A randomized, placebo‑controlled trial of diindolylmethane in women: Effects on biomarkers of breast cancer risk. Nutrition and Cancer, 68(7), 1163–1170.
Tracy, L. M., Ioannou, L., Baker, K. S., et al. (2022). Autonomic nervous system and inflammation in musculoskeletal pain: A systematic review. European Journal of Pain, 26(5), 1093–1113.
Virili, C., Centanni, M., et al. (2018). Gut microbiome and thyroid autoimmunity. Endocrine Reviews, 39(5), 595–620.
Wessells, K. R., & Brown, K. H. (2012). Estimating the global prevalence of zinc deficiency. PLoS ONE, 7(11), e50568.
Winther, K. H., Rayman, M. P., Bonnema, S. J., & Hegedüs, L. (2020). Selenium in thyroid disorders—essential knowledge for clinicians. Clinical Endocrinology, 93(3), 285–292.
Zava, T. T., & Zava, D. T. (2011). Assessment of Japanese iodine intake based on seaweed consumption. Thyroid Research, 4, 14.
Zeligs, M. A., & Brown, D. (2019). DIM and estrogen metabolism. Integrative Cancer Therapies, 18, 1534735419869584.
Zhang, X., & Santella, R. M. (2012). Evidence for DNA damage by estrogen quinones. Cancer Prevention Research, 5(6), 740–748.
Zhang, J., et al. (2016). Diindolylmethane and estrogen metabolism. Food & Function, 7(7), 3314–3321.
Zimmermann, M. B., & Andersson, M. (2021). Update on iodine status worldwide. Current Opinion in Endocrinology, Diabetes and Obesity, 28(5), 399–406.
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
